Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-11 · accession 0001437749-24-034595 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-11-11 | TGTX | Charney Laurence N | Dir | S - Sale | $30.20 | -25.0K | 212.5K | -11% | -$755.0K | |
| 2024-11-12 | 2024-11-12 | TGTX | Charney Laurence N | Dir | G - Gift | $0.00 | -5,000 | 207.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | S | D | 25,000 | $30.20 | 212,479 | D | — | — | (F1) Reflects the weighted average sale price. The range of prices for the shares sold was $30.17 to $30.29. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |
| 2 | Common | Common Stock | 2024-11-12 | G | D | 5,000 | $0.00 | 207,479 | D | — | — | (F3) Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |